Sbi Securities Co., Ltd. Spero Therapeutics, Inc. Transaction History

Sbi Securities Co., Ltd.

  • $3.9 Trillion
  • Q3 2025

A detailed history of Sbi Securities Co., Ltd. transactions in Spero Therapeutics, Inc. stock. As of the latest transaction made, Sbi Securities Co., Ltd. holds 10 shares of SPRO stock, worth $24. This represents 0.0% of its overall portfolio holdings.

Number of Shares
10
Previous 62 83.87%
Holding current value
$24
Previous $180,000 89.44%
% of portfolio
0.0%
Previous 0.0%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2025

Nov 04, 2025
SELL
$1.83 - $3.04 $95 - $158
-52 Reduced 83.87%
10 $19,000
Q2 2025

Aug 07, 2025
BUY
$0.56 - $3.02 $1 - $6
2 Added 3.33%
62 $180,000
Q1 2025

May 01, 2025
SELL
$0.72 - $1.1 $110 - $168
-153 Reduced 71.83%
60 $43,000
Q4 2024

Feb 05, 2025
BUY
$0.92 - $1.33 $195 - $283
213 New
213 $219,000

About Spero Therapeutics, Inc.

SPRO Quotes by TradingView
  • Ticker SPRO
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 35,067,500
  • Market Cap $84.5M
  • Description
  • Spero Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on identifying, developing, and commercializing treatments for multi-drug resistant (MDR) bacterial infections and rare diseases in the United States. The company's product candidates include tebipenem pivoxil hydrobromide (HBr), an oral carbapenem-class antibiotic to ...
More about SPRO
Track This Portfolio

Track Sbi Securities Co., Ltd. Portfolio

Follow Sbi Securities Co., Ltd. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Sbi Securities Co., Ltd., based on Form 13F filings with the SEC.

News

Stay updated on Sbi Securities Co., Ltd. with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email